After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
lack of face, collapse in J&K; How the exit of Ghulam Nabi Azad will hurt Congress
The exit of Ghulam Nabi Azad from Congress appears to be just another episode of the series of le
Allu Arjun's much-awaited film 'Pushpa 2: The Rule' is all set to release on the big screen on De
Pakistan is facing its worst economic crisis. Even after the change of power in Pakistan, inflati
Why is America not giving nuclear submarines to India? France will help!
On 16 September Indian Navy officials announced the US, UK, and Australia military alliance AUKUS
Noida: Injections used to treat black fungus disappear from the market, ABP Ganga investigates
Noida: In Noida, Forum-300, now used to cure black fungus (mucormycosis), has been reduced in the
America's team of rocket scientists had requested India to share the technology and equipment of
Virat Kohli and Anushka Sharma reached the Mahakal temple on Saturday morning. Here both of them
KM Chandrasekhar, who was a cabinet secretary in the Manmohan government, has made a big disclosu
FMGE December 2022: The process of applying for the Foreign Medical Graduate Examination/FMGE Dec
Gujarat Election 2022: The election of Gujarat stuck between these 'three models'! Who will win?
In the elections to be held in Gujarat, this time there will be a test of 'three models. Number o
